Cargando…
A vaccine to prevent initial loss of cognition and eventual Alzheimer's disease in elderly persons
Prevention is better than cure and prevention of Alzheimer's disease (AD) may be possible. In elderly persons who are cognitively normal, synaptic hypometabolism as shown by reduced cerebral uptake of fluorodeoxyglucose ((18)F‐FDG), provides a premonitory signal of potential, future loss of cog...
Autor principal: | Fessel, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864087/ https://www.ncbi.nlm.nih.gov/pubmed/33598529 http://dx.doi.org/10.1002/trc2.12126 |
Ejemplares similares
-
The potential for one drug, administered at the earliest preclinical stage, to prevent the subsequent decline of cognition that eventuates in dementia
por: Fessel, Jeffrey
Publicado: (2020) -
Prevention of Alzheimer's disease by treating mild cognitive impairment with combinations chosen from eight available drugs
por: Fessel, Jeffrey
Publicado: (2019) -
Supplemental thiamine as a practical, potential way to prevent Alzheimer's disease from commencing
por: Fessel, Jeffrey
Publicado: (2021) -
Does synaptic hypometabolism or synaptic dysfunction, originate cognitive loss? Analysis of the evidence
por: Fessel, Jeffrey
Publicado: (2021) -
Caveolae, CD109, and endothelial cells as targets for treating Alzheimer's disease
por: Fessel, Jeffrey
Publicado: (2020)